VenoStent
Houston
About VenoStent
VenoStent is a clinical-stage tissue engineering company that’s developed tunable, bioabsorbable smart polymer wraps in order to fundamentally transform the 5 million vascular surgeries performed each year. The company's technology is made from a new class of shape-memory polymers that are primarily used as an external stent in coronary artery bypass surgery and do not require sutures, allowing doctors to reduce surgery time, infection risk, and wound resuming in hemodialysis patients while also reducing failure from vein occlusion.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $29.8M
- Funding stage: Early Stage Venture
- Last round: Series A (Jun 2024)
- Website: venostent.com
Industries & Categories
Advanced Materials, Biotechnology, Health Care, Life Science, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/venostent-114663 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.